1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology Analysis & Statistics 2020 - United States (p20)

Biotechnology Analysis & Statistics 2020 - United States (p20)

Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

All regions

571-600 of about 4400 reports

Tyrosine Protein Kinase ITK/TSK - Pipeline Review, H1 2020

  • $ 3500
  • February 2020
  • 66 pages

Tyrosine Protein Kinase ITK/TSK - Pipeline Review, H1 2020 Summary Tyrosine Protein Kinase ITK/TSK (Interleukin 2 Inducible T Cell Kinase or T Cell Specific Kinase or Kinase EMT or Tyrosine Protein Kinase ...

  • Biotechnology
  • Immunotherapy
  • Therapy
  • United States
  • Novartis AG

Frataxin Mitochondrial - Pipeline Review, H1 2020

  • $ 3500
  • February 2020
  • 55 pages

Frataxin Mitochondrial - Pipeline Review, H1 2020 Summary Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) pipeline Target constitutes close to 14 molecules. Out of which approximately ...

  • Biotechnology
  • Therapy
  • United States
  • Product Initiative
  • Pfizer Inc.

Alpha L-Iduronidase - Pipeline Review, H1 2020

  • $ 3500
  • February 2020
  • 64 pages

Alpha L-Iduronidase - Pipeline Review, H1 2020 Summary Alpha L-Iduronidase (IDUA or EC 3.2.1.76) pipeline Target constitutes close to 13 molecules. Out of which approximately 12 molecules are developed ...

  • Biotechnology
  • Endocrine Disease
  • Medical Biotechnology
  • Therapy
  • United States

N Sulphoglucosamine Sulphohydrolase - Pipeline Review, H1 2020

  • $ 3500
  • February 2020
  • 60 pages

N Sulphoglucosamine Sulphohydrolase - Pipeline Review, H1 2020 Summary According to the recently published report ’N Sulphoglucosamine Sulphohydrolase - Pipeline Review, H1 2020’; N Sulphoglucosamine ...

  • Biotechnology
  • Therapy
  • United States
  • Product Initiative
  • Abeona Therapeutics, Inc.

Prostate Specific Antigen - Pipeline Review, H1 2020

  • $ 3500
  • February 2020
  • 78 pages

Prostate Specific Antigen - Pipeline Review, H1 2020 Summary Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) - Prostate-specific ...

  • Biotechnology
  • Immunotherapy
  • Monoclonal Antibody
  • Prostate Cancer
  • United States

Endoplasmin - Pipeline Review, H1 2020

  • $ 3500
  • February 2020
  • 52 pages

Endoplasmin - Pipeline Review, H1 2020 Summary Endoplasmin (94 kDa Glucose Regulated Protein or Heat Shock Protein 90 kDa Beta Member 1 or Tumor Rejection Antigen 1 or gp96 Homolog or HSP90B1) - Heat ...

  • Biotechnology
  • Hospital
  • Therapy
  • Vaccine
  • United States

Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline Review, H1 2020

  • $ 2000
  • February 2020
  • 106 pages

Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline Review, H1 2020, ...

  • Biotechnology
  • Therapy
  • United States
  • Product Initiative
  • Kamada Ltd.

Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) - Pipeline Review, H1 2020

  • $ 2000
  • February 2020
  • 99 pages

Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Granulomatosis with Polyangiitis - Pipeline ...

  • Biotechnology
  • Monoclonal Antibody
  • Therapy
  • United States
  • Product Initiative

2020 US Diagnostics Market: Shares and Segment Forecasts for 500 Test

  • $ 4850
  • February 2020
  • 101 pages

2020 US Diagnostics Market: Shares and Segment Forecasts for 500 Tests--Blood Banking, Cancer, Coagulation, Clinical Chemistry, Flow Cytometry, Hematology, Immunodiagnostics, Infectious Diseases, Microbiology, ...

  • Biotechnology
  • Diagnostics
  • In Vitro Diagnostics
  • United States
  • Demand

2020 Adenovirus Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies , Latest Instrumentation, Opportunities for Suppliers

  • $ 2500
  • February 2020
  • 200 pages

2020 Adenovirus Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies , Latest Instrumentation, Opportunities for Suppliers The report presents a detailed analysis of the ...

  • Biotechnology
  • Medical Biotechnology
  • Europe
  • France
  • United States

Nasal Polyps (Nasal Polyposis) - Pipeline Review, H1 2020

  • $ 2000
  • February 2020
  • 107 pages

Nasal Polyps (Nasal Polyposis) - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Nasal Polyps - Pipeline Review, H1 2020, provides an overview of the ...

  • Biotechnology
  • Respiratory Disease
  • Therapy
  • United States
  • Product Initiative

Gene Therapy Market Size, Share & Trends Analysis Report By Indication, By Vector Type, By Region And Segment Forecasts, 2020 - 2027

  • $ 5950
  • February 2020
  • 160 pages

Gene Therapy Market Size, Share & Trends Analysis Report By Indication (Acute Lymphoblastic Leukemia, Large B-cell Lymphoma), By Vector Type, By Region, And Segment Forecasts, 2020 - 2027 The global gene ...

  • Biotechnology
  • Gene Therapy
  • Medical Biotechnology
  • United States
  • Market Size

Dystrophin - Pipeline Review, H1 2020

  • $ 3500
  • February 2020
  • 122 pages

Dystrophin - Pipeline Review, H1 2020 Summary Dystrophin (DMD) pipeline Target constitutes close to 49 molecules. Out of which approximately 43 molecules are developed by companies and remaining by the ...

  • Biotechnology
  • Gene Therapy
  • Neurological Disorder
  • Therapy
  • United States

Human Cytomegalovirus Envelope Glycoprotein B - Pipeline Review, H1 2020

  • $ 3500
  • February 2020
  • 59 pages

Human Cytomegalovirus Envelope Glycoprotein B - Pipeline Review, H1 2020 Summary Human Cytomegalovirus Envelope Glycoprotein B (gB) pipeline Target constitutes close to 9 molecules. Out of which approximately ...

  • Biotechnology
  • Medical Biotechnology
  • United States
  • Product Initiative
  • VBI Vaccines Inc.

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2020

  • $ 2000
  • February 2020
  • 880 pages

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hodgkin Lymphoma - Pipeline Review, H1 2020, provides an ...

  • Biotechnology
  • Lymphoma
  • Medical Biotechnology
  • United States
  • Merck & Co., Inc.

Influenza A Virus, H3N2 Subtype Infections - Pipeline Review, H1 2020

  • $ 2000
  • February 2020
  • 156 pages

Influenza A Virus, H3N2 Subtype Infections - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H3N2 Subtype Infections - Pipeline Review, ...

  • Biotechnology
  • Influenza
  • Pharmaceutical
  • Vaccine
  • United States

Bone Marrow Transplant Rejection - Pipeline Review, H1 2020

  • $ 2000
  • February 2020
  • 751 pages

Bone Marrow Transplant Rejection - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Bone Marrow Transplant Rejection - Pipeline Review, H1 2020, provides ...

  • Biotechnology
  • Healthcare
  • Specialty Hospital
  • Transplantation
  • United States

Ragweed Pollen Allergy - Pipeline Review, H1 2020

  • $ 2000
  • February 2020
  • 35 pages

Ragweed Pollen Allergy - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Ragweed Pollen Allergy - Pipeline Review, H1 2020, provides an overview of the ...

  • Allergy
  • Allergy Immunotherapy
  • Therapy
  • United States
  • Biomay AG

Osteogenesis Imperfecta - Pipeline Review, H1 2020

  • $ 2000
  • February 2020
  • 63 pages

Osteogenesis Imperfecta - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Osteogenesis Imperfecta - Pipeline Review, H1 2020, provides an overview of ...

  • Biotechnology
  • HIV AIDS
  • Therapy
  • United States
  • Product Initiative

Crigler-Najjar Syndrome - Pipeline Review, H1 2020

  • $ 2000
  • February 2020
  • 38 pages

Crigler-Najjar Syndrome - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Crigler-Najjar Syndrome - Pipeline Review, H1 2020, provides an overview of ...

  • Biotechnology
  • Cell Therapy
  • Therapy
  • United States
  • Promethera Biosciences S.A.

Osteoarthritis - Pipeline Review, H1 2020

  • $ 2000
  • February 2020
  • 345 pages

Osteoarthritis - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis - Pipeline Review, H1 2020, provides an overview of the Osteoarthritis ...

  • Arthritis
  • Biotechnology
  • Pharmaceutical
  • Therapy
  • United States

Crohn’s Disease (Regional Enteritis) - Pipeline Review, H1 2020

  • $ 2000
  • February 2020
  • 623 pages

Crohn’s Disease (Regional Enteritis) - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Crohn’s Disease - Pipeline Review, H1 2020, provides an overview ...

  • Biotechnology
  • Pathology
  • Pharmaceutical
  • Therapy
  • United States

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2020

  • $ 2000
  • February 2020
  • 211 pages

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2020, ...

  • Biotechnology
  • Leukemia
  • Pharmaceutical
  • Therapy
  • United States

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2020

  • $ 2000
  • February 2020
  • 163 pages

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Idiopathic Thrombocytopenic Purpura ...

  • Autoimmune Disease
  • Biotechnology
  • Blood Disease
  • United States
  • Rigel Pharmaceuticals, Inc.

Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2020

  • $ 2000
  • February 2020
  • 558 pages

Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure - Pipeline Review, H1 2020, provides ...

  • Biotechnology
  • Cardiovascular Disease
  • Heart Failure
  • Therapy
  • United States

Batten Disease - Pipeline Review, H1 2020

  • $ 2000
  • February 2020
  • 92 pages

Batten Disease - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Batten Disease - Pipeline Review, H1 2020, provides an overview of the Batten Disease ...

  • Biotechnology
  • Dementia
  • Therapy
  • United States
  • Product Initiative

Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2020

  • $ 2000
  • February 2020
  • 106 pages

Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Juvenile Macular Degeneration (Stargardt Disease) ...

  • Biotechnology
  • Eye Disease
  • Ophthalmology
  • Therapy
  • United States

Cell Therapy Market Size, Share & Trends Analysis Report By Use-type, By Therapy Type, By Region And Segment Forecasts, 2020 - 2027

  • $ 5950
  • February 2020
  • 125 pages

Cell Therapy Market Size, Share & Trends Analysis Report By Use-type (Research, Commercialized, Musculoskeletal Disorders), By Therapy Type (Autologous, Allogeneic), By Region, And Segment Forecasts, 2020 ...

  • Biotechnology
  • Cell Therapy
  • Medical Biotechnology
  • United States
  • Market Size

Single Cell Analysis Market Size, Share & Trends Analysis Report By Product, By Application, By End Use And Segment Forecasts, 2020 - 2027

  • $ 5950
  • February 2020
  • 150 pages

Single Cell Analysis Market Size, Share & Trends Analysis Report By Product, By Application (IVF, Cancer, Immunology, Neurology, Stem Cell, Non-invasive Prenatal Diagnosis), By End Use, And Segment Forecasts, ...

  • Biotechnology
  • Cell Therapy
  • Medical Biotechnology
  • United States
  • Demand

2020 US HIV/AIDS Diagnostics Market: Supplier Shares and Segment Forecasts for HIV 1/2, Combo, Ag, NAT and Western Blot Assays

  • $ 1450
  • February 2020
  • 60 pages

2020 US HIV/AIDS Diagnostics Market: Supplier Shares and Segment Forecasts for HIV 1/2, Combo, Ag, NAT and Western Blot Assays This DataPack presents the US test volume and sale forecasts for HIV-1/2/Combo, ...

  • Blood Supply
  • Diagnostics
  • Immunodiagnostics
  • United States
  • Demand

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on